Skip to Main Content

Paper Details

Bevacizumab for the treatment of non-small cell lung cancer patients with synchronous brain metastases.
Sci Rep
15
2019
Bevacizumab, NSCLC, bevacizumab, brain metastases, cancer, intracranial disease, non-small cell lung cancer, patients, primary brain tumors, synchronous brain metastases, vasogenic edema
Author NameAffiliation
Priya KumthekarNorthwestern University Feinberg School of Medicine
Andrew E SloanUniversity Hospitals Cleveland Medical Center, Seidman Cancer Center, and the Case Comprehensive Cancer Center
Jill S Barnholtz-SloanCase Western Reserve University School of Medicine
Jill S Barnholtz-SloanCase Western Reserve University School of Medicine
Jill S Barnholtz-SloanCase Western Reserve University School of Medicine
Jill S Barnholtz-SloanCase Western Reserve University School of Medicine
  • 1 - 6

Datasets

Release 1.2